PRAME and breast cancer: Furthermore, SHAP results reveal that higher expression levels of TSPYL5, ATP5E, CA9, NUP210, SLC37A1, ARIH1, PSMD7, UBQLN1, PRAME, and UBE2T are associated with an increased risk of BC metastasis.